Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) again urged the U.S. EPA to abandon its ethylene oxide (EtO) risk assessment value for one that is more feasible, based on the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither…
WASHINGTON and SAN DIEGO – February 10, 2020 – The Advanced Medical Technology Association® (AdvaMed®) and Biocom, the association representing the California life science industry, today announced a joint partnership to…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the signing into law of the United States-Mexico-Canada Agreement (USMCA) by…
WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), issued the following statement on the emergence of the coronavirus:
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on President Trump’s signing of legislation to repeal the medical device excise…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the…